Doctors test HIV drugs as potential Alzheimer's treatment
NCT ID NCT07210528
Summary
This early-stage study is testing whether two HIV medications (emtricitabine and Descovy) are safe for people with mild cognitive impairment, which often leads to Alzheimer's disease. Researchers want to see if these drugs, which block a specific enzyme, might help slow memory decline by targeting a process linked to Alzheimer's. The 3-month trial involves 48 participants who will take either the active drugs or placebo pills while researchers monitor side effects and early signs of effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT(MCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National University Hospital
RECRUITINGSingapore, Singapore
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.